Services & Capabilities

Bioanalytical, Cell-Based, and immunogenicity Assays

Bioanalytical, cell-based, and immunogenicity assays are important considerations in safety evaluations.

BRT Labs designs and validates approaches to test the immunogenicity potential of therapeutic products in early-stage drug development. Our testing services provide valuable information for assessing immunogenicity and identification of biomarkers.

Models & Applications
  • Immunogenicity testing and assay development
  • Cell-based assays
  • Complement, cytokine, and biomarker analyses
Assays & Platforms
  • Immunoassay development/ validation/ implementation
  • T-cell function and proliferation
  • Vaccine efficacy
    • Anti-vaccine antibody responses
    • Hemagglutination assays
  • ADCC / ADCP / CDC and cell-based assays
  • Cell-based neutralization assays
  • PBMC isolation and evaluation
  • ELISA (absorbance, fluorescence, luminescence, electrochemiluminescence)
  • ELISpot
  • Flow cytometry
  • Multiplex technologies
  • Meso Scale Discovery (MSD)

Learn MOre About
Our In Vitro Test Offerings

Learn More

Starting a study?

request a quote
BRT Logo_Primary
Facebook Linkedin Instagram

Main Office

Service Areas

Site Links

Join Our Mailing List

Ⓒ 2024 - All Rights Are Reserved